Immediate Impact

8 from Science/Nature 74 standout
Sub-graph 1 of 22

Citing Papers

The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
2024 Standout
1 intermediate paper

Works of Steven Applebaum being referenced

TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer.
2022
Phase I Study of PD 0332991, a Novel, Oral, Cyclin-D Kinase (CDK) 4/6 Inhibitor in Combination with Letrozole, for First-Line Treatment of Metastatic Post-Menopausal, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer.
2009

Author Peers

Author Last Decade Papers Cites
Steven Applebaum 64 44 5 214 144 9 327
Dalia Kalabat 42 36 127 72 12 333
Chih-Hung Shu 52 9 109 83 14 355
Serge‐Daniel Le Bon 9 6 195 120 10 294
Mayuko Inoue 22 4 66 42 13 319
Sarah Kurtenbach 9 4 123 59 11 314
Felix C. E. Vogel 16 14 69 19 12 308
Paul Scholz 6 10 242 88 14 326
Benjamin Kalbe 11 12 247 89 13 324
Hani Shayya 7 8 103 58 8 289
Adrien Acquistapace 12 9 53 30 9 317

All Works

Loading papers...

Rankless by CCL
2026